JP Morgan Private Wealth Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,614	Closed	-$336K	–	2105
2021 Q4	$336K	Sell	3,614 -1,328	-27%	-$87.5K	﹤0.01%	1704
2021 Q3	$294K	Sell	4,942 -553	-10%	-$32.7K	﹤0.01%	1702
2021 Q2	$375K	Buy	5,495 +649	+13%	+$42.3K	﹤0.01%	1597
2021 Q1	$336K	Sell	4,846 -185	-4%	-$14.2K	﹤0.01%	1483
2020 Q4	$387K	Buy	+5,031	New	+$377K	﹤0.01%	1392

JP Morgan Private Wealth Advisors's ARNA Position: Q1 2022 in Review

JP Morgan Private Wealth Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 3,614 shares — an estimated $336K sold.

JP Morgan Private Wealth Advisors first reported a position in ARNA in Q4 2020 and held it in 5 quarters. The position peaked at $387K in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

JP Morgan Private Wealth Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 3,614 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $336K.
JP Morgan Private Wealth Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2020 and held it in 5 quarters.
JP Morgan Private Wealth Advisors's Arena Pharmaceuticals Inc position peaked at $387K in Q4 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2022, filed 16 May 2022.